Karonda

<h3> Absolute Contraindications of Karonda </h3> <h4>On active antidiabetic therapy / prone to hypoglycaemia [Low blood sugar risk]</h4> <ul> <li> ⚠️</li> <li> Recommendation: If you are taking insulin or strong blood-sugar lowering pills (sulfonylureas, meglitinides) do not take Karonda products without medical supervision - risk of low blood sugar.</li> <li> Reasoning: Animal and islet studies show Karonda extracts can significantly lower blood glucose and increase insulin secretion; when combined with pharmaceutical hypoglycemic drugs the effects can be additive and may produce symptomatic hypoglycemia.</li> <li> Scientific_Study_Title: Antidiabetic potential of unripe Carissa carandas Linn. fruit extract</li> <li> Scientific_Study_Authors: Prakash R. Itankar, Sarika J. Lokhande, Prashant R. Verma, Sumit K. Arora, Rajesh A. Sahu, Arun T. Patil</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21439367/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: In an experimental study, ethyl-acetate and methanol fractions of unripe Carissa carandas fruit at 400 mg/kg produced major reductions in elevated blood glucose in alloxan-induced diabetic rats (48% and 64.5% reductions after 24 hours for crude and ethyl-acetate fractions respectively). The authors measured polyphenolic and flavonoid contents and linked these phytochemicals to glucose-lowering activity. The magnitude of glucose lowering in these animal models indicates significant pharmacologic hypoglycaemic potential that could add to the effect of conventional antidiabetic medicines.</p> <p>Short quoted phrase (≤25 words): "has significantly lowered the elevated blood glucose levels by 48% and 64.5%... at dose level of 400 mg/kg." </p> </li> </ul> <h4>Known or symptomatic hypotension / on antihypertensive drugs [Low blood pressure risk]</h4> <ul> <li> 🩺</li> <li> Recommendation: Avoid Karonda extracts if you have low blood pressure or take blood-pressure medicines unless your clinician monitors you closely (dose adjustments may be needed).</li> <li> Reasoning: Pharmacodynamic data in animals show Karonda extract can produce rapid, dose-dependent falls in arterial pressure and heart rate by an endothelium-dependent vasorelaxant mechanism - combining this with antihypertensive drugs risks excessive blood-pressure reduction.</li> <li> Scientific_Study_Title: Pharmacodynamic study on acute hypotensive activities of Carissa carandas extract in normal rats</li> <li> Scientific_Study_Authors: Sumbul Shamim, Syed Iqbal Ahmad</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22713944/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: In conscious rat models given intravenous doses of Carissa carandas ethanol extract (5-45 mg/kg), blood pressure fell in a dose-dependent manner; the highest dose produced about a 50% decrease in mean arterial blood pressure and also reduced heart rate. The authors attributed the hypotension to stimulation of endothelial muscarinic receptors with subsequent release of endothelium-derived relaxing factors (notably nitric oxide) leading to vascular smooth muscle relaxation.</p> <p>Short quoted phrase (≤25 words): "produced dose dependent reduction in arterial blood pressure... 50.75% decrease in MABP at 45 mg/kg." </p> </li> </ul> <h4>Chronic very high-dose use / pre-existing severe liver or kidney disease [Organ safety concern]</h4> <ul> <li> 🧪</li> <li> Recommendation: Avoid prolonged, very high-dose Karonda extracts if you have significant liver or kidney disease unless supervised by a specialist; use standard doses only after medical review.</li> <li> Reasoning: Subchronic and chronic animal studies report that while acute and moderate subacute dosing may be tolerated, very large chronic doses produced histological changes in visceral organs - raising caution for patients with compromised hepatic or renal reserve.</li> <li> Scientific_Study_Title: Acute, Subacute and Subchronic Toxicological Studies of Carissa Carandas Leaves (Ethanol Extract)</li> <li> Scientific_Study_Authors: Sumbul Shamim et al.</li> <li> Scientific_Study_Link: https://jduhs.com/index.php/jduhs/article/view/1439</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: Toxicology testing in rats using aqueous:ethanol (1:1) leaf extract reported no mortality or gross organ changes at acute and subacute doses; however, in chronic dosing experiments at very high oral doses (reported up to 5000 mg/kg), histopathological alterations were observed in liver, heart, kidney and spleen. The authors conclude that lower and short-term exposures appeared safe in their models, but extremely high long-term exposures produced tissue changes, warranting caution in susceptible humans.</p> <p>Short quoted phrase (≤25 words): "chronic toxicity at a dose of 5000 mg/kg (p.o.) showed some histological changes in these organs." </p> </li> </ul> <h3> Relative Contraindications of Karonda </h3> <h4>Use with K-ATP channel openers (e.g., diazoxide) - may blunt/alter glucose effects</h4> <ul> <li> 🔁</li> <li> Recommendation: If you are prescribed diazoxide or similar agents for insulin control, discuss Karonda use with your clinician - interactions in insulin secretion pathways may occur.</li> <li> Reasoning: Mechanistic pharmacology using isolated pancreatic islets shows Karonda-induced insulin release is sensitive to K-ATP openers; co-administration can modify the expected insulin response and glucose regulation.</li> <li> Scientific_Study_Title: Antidiabetic effect of Carissa carandas in rats and the possible mechanism of its insulin secretagogues activity in isolated pancreatic islets</li> <li> Scientific_Study_Authors: Rambir Singh, Mansi Shrivastava, Poonam Sharma</li> <li> Scientific_Study_Link: https://pubs.thesciencein.org/journal/index.php/jbts/article/view/90</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: In isolated pancreatic islet experiments the aqueous extract increased insulin secretion at high glucose; this insulinotropic effect was significantly reduced by diazoxide (a K-ATP opener), indicating that the extract acts at least partly by closing K-ATP channels. Thus, drugs that open or otherwise modulate K-ATP channels could oppose or unpredictably alter Karonda’s insulin effects.</p> <p>Short quoted phrase (≤25 words): "AECC induced insulin secretion... was significantly reduced by Diazoxide." </p> </li> </ul> <h4>Use with calcium-channel blockers (possible modulation of insulin effect)</h4> <ul> <li> 💊</li> <li> Recommendation: If you use L-type calcium-channel blockers (e.g., nimodipine, verapamil), monitor glucose control if you start Karonda; dose adjustments of diabetes therapy may be needed.</li> <li> Reasoning: Experimental islet work showed the insulin-releasing effect of Karonda is reduced by L-type Ca2+ channel blockers, implying these drugs can alter Karonda’s glucose-lowering action and lead to unpredictable glycemic responses.</li> <li> Scientific_Study_Title: Antidiabetic effect of Carissa carandas in rats and the possible mechanism of its insulin secretagogues activity in isolated pancreatic islets (conference/experimental report)</li> <li> Scientific_Study_Authors: Rambir Singh, Poonam Sharma (conference/experimental publication)</li> <li> Scientific_Study_Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9045590/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: Incubation of pancreatic islets with the Carissa extract produced insulin secretion at high glucose which was significantly reduced when nimodipine (an L-type Ca2+ channel blocker) was present - indicating that extracellular Ca2+ influx through L-type channels is part of the extract’s mechanism. Concomitant use of Ca2+ channel blockers may therefore change the clinical glycemic effects of Karonda.</p> <p>Short quoted phrase (≤25 words): "AECC induced insulin secretion... was significantly reduced by... Nimodipine." </p> </li> </ul> <h4>Use in people taking multiple cardiovascular actives (additive haemodynamic effects)</h4> <ul> <li> ❤️</li> <li> Recommendation: If you are on combined cardiovascular therapy (multiple antihypertensives, nitrates, or drugs affecting vascular tone), consult your physician before using Karonda; monitoring is recommended.</li> <li> Reasoning: Karonda extracts have documented vasorelaxant and bradycardic actions in animals; when added to other agents that lower blood pressure or heart rate, they may amplify haemodynamic effects and require medical supervision.</li> <li> Scientific_Study_Title: Pharmacodynamic study on acute hypotensive activities of Carissa carandas extract in normal rats</li> <li> Scientific_Study_Authors: Sumbul Shamim, Syed Iqbal Ahmad</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22713944/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase: The ethanol extract produced rapid, dose-dependent falls in mean arterial blood pressure and decreased heart rate in rats. The mechanism involved muscarinic receptor stimulation on the endothelium with release of endothelial relaxing factors (including nitric oxide). Given this mechanism, combined use with other vasodilators or negative chronotropic drugs could produce exaggerated hypotension or bradycardia.</p> <p>Short quoted phrase (≤25 words): "It was concluded that the Carissa carandas Ethanol extract possess potent acute hypotensive effect." </p> </li> </ul>